FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113762.1.4.1116.168.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1116.168/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168
Version20220910
Statusactive
Date2022-09-10T01:02:30-04:00
NameDoxorubicinInjectable
TitleDoxorubicin Injectable
Realmus
Authorityhl7
Purpose(Clinical Focus: This value set contains concepts that represent the medication Doxorubicin.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Doxorubicin.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; doxorubicin pegylated liposomal.)

Resources that use this resource

ValueSet
2.16.840.1.113883.3.1444.5.200Doxorubicin
2.16.840.1.113883.3.1444.5.243Moderate Emetic Risk Intravenous Antineoplastic Agent
2.16.840.1.113883.3.1444.5.244Anthracycline Injectable

Resources that this resource uses

CodeSystem
rxnormRxNorm

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1116.168",
  "meta": {
    "versionId": "27",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "American Society of Clinical Oncology Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-04-08"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2022-09-10"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1116.168"
    }
  ],
  "version": "20220910",
  "name": "DoxorubicinInjectable",
  "title": "Doxorubicin Injectable",
  "status": "active",
  "experimental": false,
  "date": "2022-09-10T01:02:30-04:00",
  "publisher": "American Society of Clinical Oncology Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: This value set contains concepts that represent the medication Doxorubicin.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Doxorubicin.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable; doxorubicin pegylated liposomal.)",
  "compose": {
    "include": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept": [
          {
            "code": "1191138",
            "display": "doxorubicin hydrochloride 2 MG/ML Injectable Solution"
          },
          {
            "code": "1790095",
            "display": "doxorubicin hydrochloride 50 MG Injection"
          },
          {
            "code": "1790097",
            "display": "5 ML doxorubicin hydrochloride 2 MG/ML Injection"
          },
          {
            "code": "1790099",
            "display": "10 ML doxorubicin hydrochloride 2 MG/ML Injection"
          },
          {
            "code": "1790100",
            "display": "25 ML doxorubicin hydrochloride 2 MG/ML Injection"
          },
          {
            "code": "1790103",
            "display": "doxorubicin hydrochloride 10 MG Injection"
          },
          {
            "code": "1872062",
            "display": "doxorubicin hydrochloride 20 MG Injection"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:5ce9592f-9492-4187-98df-028921f2409e",
    "timestamp": "2025-05-23T18:17:53-04:00",
    "total": 7,
    "contains": [
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1191138",
        "display": "doxorubicin hydrochloride 2 MG/ML Injectable Solution"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790095",
        "display": "doxorubicin hydrochloride 50 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790097",
        "display": "5 ML doxorubicin hydrochloride 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790099",
        "display": "10 ML doxorubicin hydrochloride 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790100",
        "display": "25 ML doxorubicin hydrochloride 2 MG/ML Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1790103",
        "display": "doxorubicin hydrochloride 10 MG Injection"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version": "05052025",
        "code": "1872062",
        "display": "doxorubicin hydrochloride 20 MG Injection"
      }
    ]
  }
}